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Abstract 
Sanguinarine is a natural isoquinoline alkaloid derived from the root of Sanguinaria 
canadensis and from other poppy fumaria species, and is known to have a broad spectrum of 
pharmacological properties. Here we have found that sanguinarine, at low micromolar 
concentrations, showed a remarkably rapid killing activity against human melanoma cells. 
Time-lapse videomicroscopy showed rapid morphological changes compatible with an 
apoptotic cell death, which was further supported by biochemical markers, including caspase 
activation, poly(ADP-ribose) polymerase (PARP) cleavage and DNA breakdown. Pan-
caspase inhibition blocked sanguinarine-induced cell death. Sanguinarine treatment also 
induced an increase in intracellular calcium concentration, which was inhibited by dantrolene, 
and cleavage of BAP-31, thus suggesting a putative role for Ca2+ release from endoplasmic 
reticulum and a cross-talk between endoplasmic reticulum and mitochondria in the anti-
melanoma action of sanguinarine. Sanguinarine disrupted the mitochondrial transmembrane 
potential (ΔΨm), released cytochrome c and Smac/DIABLO from mitochondria to cytosol, 
and increased the generation of reactive oxygen species (ROS). Overexpression of Bcl-XL by 
gene transfer did not prevent sanguinarine-mediated cell death, ROS generation or release of 
mitochondrial apoptogenic proteins. However, preincubation with N-acetyl-L-cysteine (NAC) 
prevented sanguinarine-induced oxidative stress, PARP cleavage, release of apoptogenic 
mitochondrial proteins, and cell death. Pretreatment with glutathione (GSH) also inhibited the 
anti-melanoma activity of sanguinarine. Thus, pretreatment with the thiol antioxidants NAC 
and GSH abrogated the killing activity of sanguinarine. Taking together, our data indicate that 
sanguinarine is a very rapid inducer of human melanoma caspase-dependent cell death that is 
mediated by ROS generation. 
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1. Introduction 
Sanguinarine (13-methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium) is a 
natural isoquinoline alkaloid (Malikova et al., 2006) that can be found in plants of the 
Papaveraceae family, such as Sanguinaria canadensis. Sanguinarine has a broad spectrum of 
pharmacological activities, including antitumor (Faddeeva and Beliaeva, 1997), anti-bacterial 
(Mitscher et al., 1978), and anti-inflammatory (Lenfeld et al., 1981) actions. Sanguinarine has 
been reported to induce cell cycle arrest and apoptosis in distinct cancer cells (Adhami et al., 
2004; Ahmad et al., 2000; Ahsan et al., 2007; Ding et al., 2002; Holy et al., 2006; Kemeny-
Beke et al., 2006; Serafim et al., 2008; Weerasinghe et al., 2001). 
Melanoma remains one of the most deadly skin cancers and its incidence has been 
steadily rising throughout the past decades (Cho and Chiang, 2010). Chemotherapy has had 
little impact on the survival of patients with metastatic melanoma (Hersey et al., 2009). So 
far, there is no efficient therapy against melanoma, hence the need of searching for new 
effective agents. Some previous reports have shown that sanguinarine was effective in 
treating melanoma in xenograft assays (De Stefano et al., 2009), and acted as a DNA 
damaging agent and partially affected mitochondrial-mediated processes in mouse melanoma 
K1735-M2 cell line (Serafim et al., 2008). 
Mitochondria play a role in the chemotherapeutic action of a number of molecules that 
leads to cancer cell death. Mitochondrial damage, which involves permeabilization of the 
outer mitochondrial membrane, activates a series of events leading to cell death (Caroppi et 
al., 2009). The activation of the intrinsic apoptotic pathway involves release of cytochrome c 
and other proapoptotic factors from the mitochondrial intermembrane space. In the cytosol, 
cytochrome c binds to the apoptosis protease-activation factor (APAF-1) and forms a complex 
known as apoptosome, which then recruits and activates procaspase-9, thus triggering a 
cascade of events leading to apoptosis (Acehan et al., 2002). One of the consequences of 
mitochondrial dysfunction is excessive reactive oxygen species (ROS) production. Oxygen is 
initially converted to superoxide anion by electrons that can leak from both complexes I and 
III in the electron transport system present in mitochondria (Ishii, 2007). Oxidative stress 
results in damage to the cellular components, including mitochondrial structures, and 
eventually leads to apoptosis (Ishii, 2007). However, despite mitochondria constitute a major 
origin of ROS, additional sources have been reported (Vaquero et al., 2004). 
Here, we have analyzed the action of sanguinarine on human melanoma cells as well 
as the underlying mechanisms, with special relevance to the putative role of mitochondria. 
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The results reported here provide novel insights into the sanguinarine-mediated anti-
melanoma activity. 
 
2. Materials and methods 
2.1. Reagents 
Sanguinarine chloride was from Alexis Biochemicals (Lausen, Switzerland) and prepared in 
dimethyl sulfoxide (DMSO). Total volume of vehicle (DMSO) in all experiments was lower 
than 0.2%, and it rendered negligible effects (data not shown). Pan-caspase inhibitor z-VAD-
fmk was from Alexis Biochemicals (Lausen). Trypan blue, propidium iodide, RNase A, N-
acetyl-L-cysteine (NAC), dantrolene, glutathione (GSH), dihydroethidine (DHE), and BSA 
were from Sigma (St. Louis, MO). 30% Acrylamide/Bisacrylamide, ammonium persulfate, 
and N,N,N′,N′-tetramethylethylenediamine were from Bio-Rad (Hercules, CA). Hybond 
enhanced chemiluminescence (ECL) nitrocellulose membranes, and ECL Western blotting 
detection reagents were from GE Healthcare (Princeton, NJ). Fluo-4 AM, Hoechst 33342, 
3,3’-dihexyloxacarbocyanine iodide [DiOC6(3)], and tetramethyl rhodamine methyl ester 
(TMRM) were from Molecular Probes (Leiden, The Netherlands). Lipofectamine 2000 
reagent was from Invitrogen (Eugene, OR). RPMI-1640, FBS, antibiotics, L-glutamine, NaP, 
NEAA, 0.25% Trypsin-EDTA were purchased from Gibco (Carlsbad, CA). 
 
2.2. Cell culture  
The human melanoma cell lines SK-MEL-2, SK-MEL-5, SK-MEL-28 and MALME-3M were 
obtained from the American Type Culture Collection (ATCC, Manassas, VA). All these cells 
were derived from malignant melanoma. However, SK-MEL-2, SK-MEL-5 and MALME-3M 
cells were also metastatic cell lines, their metastatic sites being the skin of thigh, axillary node 
and lung, respectively. Cell lines were grown in RPMI-1640 supplemented with 15% heat-
inactivated FBS, 2 mM L-glutamine, 100 units/ml penicillin, 100 μg/ml streptomycin at 37ºC 
in 5% CO2 humidified air. For SK-MEL-2, SK-MEL-5 and SK-MEL-28 cell lines, the 
medium was also supplemented with 1 mM of sodium pyruvate (NaP) and 1% non-essential 
amino acids (NEAA). Cells were periodically tested for Mycoplasma infection and found to 
be negative. 
 
2.3. Cell viability and cell death analysis  
Sanguinarine was incubated at various concentrations with human melanoma cell lines for the 
indicated times, and then cell viability was determined by using Trypan Blue dye reagent 
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(Sigma). Non-viable cells stained blue due to Trypan Blue uptake, while viable cells excluded 
Trypan Blue and showed normal refringent cytoplasm. Cell samples were counted under the 
light microscope, and the percentage of non-viable cells was determined. Apoptotic cell death 
was analyzed in situ by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end 
labeling (TUNEL) technique using the Fluorescein Apoptosis Detection System Kit 
(Promega, Fitchburg, WI), according to the manufacturer’s instructions, labeling the 3’-OH 
ends generated by DNA fragmentation through incorporation of fluorescein-12-dUTP 
(Cabaner et al., 1999; Gavrieli et al., 1992). Fluorescent cells were visualized and scored with 
a Zeiss LSM 310 laser scan confocal microscope. 
 
2.4. Western blotting in total cell extracts 
Cells at approximately 70% of confluence (about 1.0 x 106) were lysed with 60 μl of 25 mM 
Hepes (pH 7.7), 0.3 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.1% Triton X-100, 20 mM 
β-glycerophosphate and 0.1 mM sodium orthovanadate supplemented with protease inhibitors 
(1 mM phenylmethylsulfonyl fluoride, 20 μg/ml aprotinin, 20 μg/ml leupeptin). Fifty 
micrograms of protein extract were run on SDS-polyacrylamide gels, transferred to hybond 
ECL nitrocellulose membranes, blocked with 5% (w/v) defatted milk powder in TBST (50 
mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% Tween 20) for 60 min at room temperature, and 
incubated for 1 h at room temperature, or overnight at 4ºC, with the following specific 
antibodies: anti-17 and 19 kDa active caspase-3 rabbit polyclonal antibody (1:750 dilution, 
Cell Signaling Technology, Beverly, MA); N-15 anti-50 kDa caspase-4 goat polyclonal 
antibody, that also detects the active cleaved p20 subunit (1:250 dilution, Santa Cruz 
Biotechnology, Santa Cruz, CA); anti-35 kDa caspase-7 mouse monoclonal antibody, that 
also recognizes the cleaved p11, p20 and p32 subunits (1:750 dilution, BD Biosciences, San 
Jose, CA); 1C12 anti-57 kDa caspase-8 mouse monoclonal antibody, that also detects the 
cleaved p43 and p18 subunits (1:500 dilution, Cell Signaling Technology); anti-47 kDa 
caspase-9 rabbit polyclonal antibody, that also recognizes the cleaved p10, p17 and p38 
subunits (1:250 dilution, Calbiochem, Gibbstown, NJ); C2.10 anti-116 kDa poly(ADP-ribose) 
polymerase (PARP) mouse monoclonal antibody, that also detects the 85 kDa cleavage 
product (1:750 dilution, BD Biosciences); anti-58 kDa caspase-10 rabbit polyclonal antibody, 
that also recognizes the p17 and p23 subunits (1:50 dilution, Calbiochem); C-15 anti-31 kDa 
BAP-31 goat polyclonal antibody, that also detects the 20 kDa cleavage product (1:500 
dilution, Santa Cruz Biotechnology); AC-15 anti-42 kDa β-actin mouse monoclonal antibody 
(1:5,000 dilution, Sigma). Secondary antibodies were anti-mouse biotinylated (GE 
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Healthcare, Princeton, NJ); anti-rabbit biotinylated (GE Healthcare) and anti-goat horseradish 
peroxidase (Santa Cruz Biotechnology). When secondary biotinylated antibodies were used, 
membranes were subsequently incubated with streptavidin-horseradish peroxidase conjugate 
(GE Healthcare). Signals were detected using an ECL kit (GE Healthcare). 
 
2.5. Analysis of mitochondrial protein release 
Release of apoptogenic proteins from mitochondria to cytosol was analyzed from 3 × 106 cells 
by Western blot as previously described (Gajate et al., 2003), using the following specific 
antibodies: anti-15 kDa cytochrome c mouse monoclonal antibody (1:500 dilution, BD 
Biosciences); anti-22 kDa Smac/DIABLO mouse monoclonal antibody (1:500 dilution, BD 
Biosciences); AC-15 anti-42 kDa β-actin monoclonal antibody (1:5,000, Sigma). Blots were 
then incubated with biotinylated anti-mouse inmunoglobulin antibodies (GE Healthcare), 
followed by incubation with streptavidin-horseradish peroxidase conjugate (GE Healthcare). 
Signals were developed using an ECL kit (GE Healthcare). 
 
2.6. Cytofluorimetric analysis of intracellular calcium and mitochondrial transmembrane 
potential  
To evaluate changes in intracellular calcium concentration, cells were incubated with or 
without 3 µM Sanguinarine for 2 h, and 30 min before the end of the treatment, 2 µM Fluo-4 
AM (green fluorescence) was used to measure intracellular calcium. Cells were then washed 
with PBS, harvested and analyzed on a flow cytometer FACSCalibur (Becton Dickinson, 
Franklin Lakes, NJ). To evaluate changes in mitochondrial transmembrane potential (ΔΨm), 
cells were incubated with or without 3 µM Sanguinarine for 2 h, and 30 min before the end of 
the treatment 100 nM tetramethyl rhodamine methyl ester (TMRM) (red fluorescence) 
(Molecular Probes) was added to measure mitochondrial membrane potential (∆Ψm). Cells 
were then washed with PBS, harvested and analyzed on a flow cytometer FACSCalibur 
(Becton Dickinson). In addition, mitochondrial transmembrane potential (∆Ψm) was also 
examined by incubating cells (106/ml) in PBS with 20 nM 3,3’-dihexyloxacarbocyanine 
iodide [DiOC6(3)] (green fluorescence) (Molecular Probes) for 20 min at 37°C, followed by 
analysis on a flow cytometer FACSCalibur (Becton Dickinson). 
 
2.7. Measurement of reactive oxygen species (ROS) generation by flow cytometry 
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To evaluate the generation of ROS, cells were incubated in PBS with 2 µM dihydroethidine 
(DHE) (red fluorescence after oxidation) for 40 min at 37°C, followed by analysis on a 
FACScalibur flow cytometer as previously decribed (Gajate et al., 2000). 
 
2.8. Confocal microscopy  
SK-MEL-2 cells in glass-bottom dishes were incubated with 3 µM sanguinarine for 2 h. Then, 
cells were double labeled with Fluo-4 AM (2 µM) and Hoechst 33342 (2 µg/ml), added to the 
cell culture 1 h and 30 min, respectively, or with DHE (2 µM) and Hoechst 33342 (2 µg/ml), 
added to the cell culture 40 and 30 min, respectively, before the end of drug treatment. Then, 
cells were analyzed by confocal microscopy using a Leica laser scanning confocal microscope 
(Bannockburn, IL). Fluo-4 AM signal was acquired using an air-cooled argon laser. DHE 
signal was acquired using a green He-Ne laser. Hoechst 33342 signal was obtained by using a 
violet diode laser. The antifading reagent SlowFade® Gold (Invitrogen, Eugene, OR) was 
used to preserve fluorescence signal intensity.  
 
2.9. Overexpression of bcl-xL by stable transfection 
SK-MEL-2 cells were transfected with 8 μg of pSFFV-Neo expression vector containing the 
human bcl-xL open reading frame, driven by the long terminal repeat of the splenic focus-
forming virus (pSFFV-Bcl-XL) (Mollinedo et al., 1997), by using Lipofectamine reagent 
(Invitrogen, Eurogene, OR) and following the manufacturer’s instructions. As a control, 
transfection was performed with empty pSFFV-Neo plasmid. Transfectants were selected by 
growth in complete culture medium supplemented with 800 µg/ml G418 (Sigma), and then 
grown in the presence of 250 µg/ml G418. Stable transfectants were achieved after about 30 
days. The different clones were isolated and monitored for Bcl-XL expression by Western 
blot, using the anti-17 and -26 kDa Bcl-X rabbit polyclonal antibody (1:250 dilution, BD 
Biosciences). 
 
2.10. Statistical analysis  
Data are expressed as means ± SD of the number of experiments indicated in the figure 
legends. Multiple comparisons were performed using one-way analysis of variance followed 
by a Bonferroni post hoc test. Single comparisons between two experimental groups were 
made by using Student’s t-test. Significance was accepted with p value < 0.05. 
 
3. Results 
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3.1. Sanguinarine induces a rapid killing of human melanoma cells 
We found that sanguinarine induced a rapid killing of SK-MEL-2 melanoma cancer cells 
when incubated at low micromolar concentration for only 2 h incubation, as assessed by 
Trypan blue staining (Fig. 1A). A potent melanoma cell-killing activity was evident at 3 μM 
sanguinarine when incubated for either 2 or 24 h (Fig. 1A). The tumor killing activity of 
sanguinarine was increased with drug concentration and incubation time, but sanguinarine 
induced a remarkable and strong antitumor activity at early incubation times (Fig. 1A). 
Furthermore, 3 µM sanguinarine induced a decrease in cell viability following 2 h incubation 
in a number of human melanoma cell lines, including SK-MEL-2 (47.4 ± 8.0 % cell death), 
SK-MEL-5 (21.2 ± 1.5 % cell death), SK-MEL-28 (15.6 ± 1.5 % cell death) and MALME-
3M (28.1 ± 1.7 % cell death), as assessed by Trypan blue staining (Fig. 1B). Treatment of SK-
MEL-2 cells with 3 µM sanguinarine induced an increase in non-viable cells at very early 
incubation times in a time-dependent manner (Fig. 1C), which was also confirmed by 
morphological changes (Fig. 1D). Time-lapse videomicroscopy of untreated (Supplementary 
Video 1) and 3 µM sanguinarine-treated (Supplementary Video 2) SK-MEL-2 melanoma 
cells showed a remarkably rapid killing of melanoma cells by sanguinarine, which displayed 
the typical morphological changes of apoptosis (cell shrinkage, rounding up, blebbing). The 
onset of this sanguinarine-induced killing of melanoma cells was achieved after only 25 min 
of drug incubation (Supplementary Video 2). The induction of sanguinarine-induced cell 
death by an apoptosis-like process in melanoma cells was further supported by TUNEL assay 
(data not shown). 
 
3.2. Involvement of caspase activation in sanguinarine-induced melanoma cell killing 
Because SK-MEL-2 cells were the most sensitive melanoma cells to sanguinarine treatment 
(Fig. 1B), this cell line was used in the following experiments to analyze the underlying 
mechanism involved in sanguinarine-mediated melanoma cell killing. Sanguinarine treatment 
of SK-MEL-2 cells induced a rapid activation of several caspases, including initiator caspases 
8, 10, 9 and 4, as well as executioner caspases 3 and 7 (Fig. 2A). Cleavage of the caspase-3/7 
substrate PARP, a nuclear enzyme involved in DNA repair and programmed cell death, was 
also rapidly detected (Fig. 2A). Pre-incubation of melanoma cells with the pan-caspase 
inhibitor z-VAD-fmk prevented cell killing induced by 3 µM sanguinarine after treatment for 
either 2 or 24 h incubation (Fig. 2B). These results suggest that caspase activation is required 
for sanguinarine-induced melanoma cell killing, and that several caspases are triggered by 
sanguinarine in a similar time frame. 
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 3.3. Sanguinarine increases intracellular calcium and induces BAP-31 cleavage in melanoma 
cells 
We found that sanguinarine treatment caused an increase in intracellular calcium 
concentration in SK-MEL-2 cells, as detected by Fluo-4 AM and analyzed by both confocal 
microscopy (Fig. 3A) and flow cytometry (Fig. 3B). In addition, sanguinarine induced 
cleavage of BAP-31 (Fig. 3C), an endoplasmic reticulum membrane protein that is a caspase-
8 substrate (Ng et al., 1997). The p20-BAP31 cleavage product has been shown to direct 
proapoptotic signals between endoplasmic reticulum and mitochondria (Breckenridge et al., 
2003). Interestingly, incubation of SK-MEL-2 melanoma cells with dantrolene significantly 
inhibited the killing activity of sanguinarine (Fig. 3D). Dantrolene prevents excessive Ca2+ 
release from the endoplasmic reticulum by inhibiting ryanodine receptors (Inan and Wei, 
2010; Zhao et al., 2001). These data suggest that Ca2+ release endoplasmic reticulum might 
play a role in the action of sanguinarine on melanoma cells. Our data suggest that 
sanguinarine might induce some endoplasmic reticulum-mediated responses that could affect 
mitochondria. 
 
3.4. Sanguinarine induces ROS generation, ΔΨm loss and release of mitochondrial 
apoptogenic proteins 
Next, we analyzed the effect of sanguinarine on mitochondrial-mediated cell death. 
Sanguinarine (3 μM, 2 h incubation) induced a potent and rapid generation of ROS in SK-
MEL-2 cells, as assessed by dihydroethidine (DHE) fluorescence using flow cytometry (Fig. 
4A), and confocal microscopy (Fig. 4B). Sanguinarine also promoted ΔΨm loss in SK-MEL-2 
melanoma cells in a concentration-dependent manner, as assessed by measurements of 
DiOC6(3) fluorescence (green fluorescence), a cationic probe that accumulates into 
mitochondria as a function of its potential (Fig. 4C). The increase in the percentage of 
melanoma cells with low ΔΨm following sanguinarine treatment paralleled its cell-killing 
activity (cf. Figs. 1A and 4C). Sanguinarine also promoted a dramatic ΔΨm loss in melanoma 
cells, as assessed by TMRM fluorescence (red fluorescence) to measure ∆Ψm  (Fig. 4D), and 
the release of mitochondrial cytochrome c and Smac/DIABLO to the cytosol after only 30-
min treatment (Fig. 4E). However, cytochrome oxidase subunit II, used as a marker of 
mitochondrial membrane, remained in the mitochondrial extract and was not released to the 
cytosol (data not shown). No alterations in ATP/ADP ratio or energy charge were detected 
after 30 min-, 1 h- and 2 h-drug treatment (data not shown). These results suggest that 
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sanguinarine exerts a rapid effect on mitochondrial integrity, leading to depolarization and 
release of proapoptotic proteins. 
 
3.5. Sanguinarine-mediated cell death is not prevented by Bcl-XL overexpression 
Because Bcl-XL preserves mitochondrial integrity, abrogating cytochrome c release, ΔΨm loss 
and apoptosis (Gajate and Mollinedo, 2007; Gajate et al., 2000), we overexpressed Bcl-XL in 
SK-MEL-2 cells to examine the role of mitochondria in sanguinarine-induced cell death. SK-
MEL-2 cells were stably transfected with pSFFV-bcl-xL (SK-MEL-2-Bcl-XL), containing the 
human bcl-xL open reading frame, or with control pSFFV-Neo plasmid (SK-MEL-2-Neo). 
SK-MEL-2-Neo cells behaved as non-transfected SK-MEL-2 cells in all parameters studied. 
Western blot analysis showed a high expression of Bcl-XL in SK-MEL-2-Bcl-XL cells as 
compared to the low Bcl-XL endogenous level of SK-MEL-2-Neo cells (Fig. 5A, inset). 
Interestingly, while Bcl-XL overexpression inhibited cell death induced by a number of 
proapoptotic agents, including edelfosine and berberine (data not shown), as previously 
reported (Burgeiro et al., 2011; Gajate and Mollinedo, 2007), it did not protect against cell 
death, PARP degradation, ROS generation or the release of mitochondrial cytochrome c and 
Smac/DIABLO to cytosol induced by sanguinarine (Fig. 5, A-D). These data show that the 
action of sanguinarine on mitochondria is not inhibited by Bcl-XL overexpression. 
 
3.6. N-Acetyl-L-cysteine and glutathione (GSH) protect melanoma cells against sanguinarine-
induced cell death 
Pretreatment of SK-MEL-2 cells with the antioxidant N-acetyl-L-cysteine (NAC) prevented 
sanguinarine-induced cell death (Fig. 6A) and PARP cleavage (Fig. 6B). NAC pretreatment 
also blocked oxidative stress (Fig. 6C), and release of mitochondrial cytochrome c and 
Smac/DIABLO to the cytosol (Fig. 6D). Because NAC is known to induce intracellular 
glutathione (GSH) levels by acting as a precursor for the synthesis of GSH (Duyndam et al., 
2001; Menon et al., 2005), we also examined the action of GSH on the cell killing activity of 
sanguinarine. As shown in Fig. 7, we found that GSH inhibited significantly the anti-
melanoma activity of sanguinarine when incubated for either 2 or 24 h. Thus, pretreatment 
with the thiol antioxidants NAC and GSH abrogated the cell-killing activity of sanguinarine. 
These results suggest the involvement of ROS generation in the rapid action of sanguinarine 
on mitochondria and cell killing. 
 
4. Discussion 
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Here, we report that sanguinarine induces an extremely rapid caspase- and ROS-dependent 
cell killing in human melanoma cells. Time-lapse videomicroscopy showed the rapid 
shrinkage, rounding up and blebbing of melanoma cells following sanguinarine treatment. 
These morphological changes, together with a positive TUNEL reaction, suggest the 
induction of sanguinarine-induced cell death by an apoptosis-like process in melanoma cells. 
The activation of different caspases upon sanguinarine addition suggests the triggering of 
distinct signaling pathways. The rapid activation of caspases-4 and -9 suggests the 
involvement of endoplasmic reticulum and mitochondria in the antitumor action of 
sanguinarine. 
Adenoviral expression of the p20 cleavage fragment from the endoplasmic reticulum 
membrane protein BAP-31 has been reported to cause an early release of Ca2+ from the 
endoplasmic reticulum, concomitant Ca2+ uptake by mitochondria, and mitochondrial 
recruitment of Drp1, a dynamin-related protein that mediates scission of the outer 
mitochondrial membrane, resulting in fission of the mitochondrial network (Breckenridge et 
al., 2003). Generation of the p20-BAP-31 fragment was detected after 2 h sanguinarine 
incubation, coincident with caspase-8 activation. Sanguinarine also caused an increase in 
cytosolic [Ca2+]. Elevation of cytosolic [Ca2+] can result from Ca2+-influx from the 
extracellular space or from Ca2+-release from intracellular stores, especially from endoplasmic 
reticulum (Bergner and Huber, 2008). The inhibition of sanguinarine-induced cell killing by 
dantrolene, a ryanodine receptor inhibitor that prevents Ca2+ release from the endoplasmic 
reticulum  (Inan and Wei, 2010; Zhao et al., 2001), further supports a role of endoplasmic 
reticulum in the anti-melanoma action of sanguinarine. The increase in cytoplasmic [Ca2+] 
following sanguinarine treatment might originate, at least in part, from extracellular Ca2+, as 
sanguinarine-induced cardiac muscle contracture has been shown to be inhibited by chelation 
of extracellular Ca2+ or addition of the Ca  antagonist 2+ La  (Hu et al., 2005)3+ . In this regard, it 
is worthy to note that the process known as calcium-induced calcium release (CICR), by 
which calcium is able to activate calcium release from intracellular Ca2+ stores (e.g.: 
endoplasmic reticulum), is primarily mediated by the the ryanodine receptor and Ca2+ release 
from the endoplasmic reticulum (Islam et al., 1992; Verkhratsky and Shmigol, 1996). In 
addition, we have found that pretreatment of SK-MEL-2 cells with the extracellular calcium 
chelator EGTA partially reduces the killing activity of sanguinarine (data not shown). 
Previous studies showed that sanguinarine treatment increased cytosolic levels of 
cytochrome c, and active forms of caspases-3, -7, -8 and -9, leading to PARP cleavage and 
apoptotic cell death in immortalized human HaCaT keratinocytes (Adhami et al., 2003). Our 
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data show that sanguinarine compromised mitochondrial integrity, resulting in mitochondrial 
depolarization and release of apoptogenic proteins. However, overexpression of Bcl-XL, an 
antiapoptotic protein that mediates its effects through heterodimerization with the BH3 region 
of proapoptotic molecules, did not prevent sanguinarine-induced cell death, PARP cleavage, 
release of mitochondrial apoptogenic proteins, or oxidative stress response. It has been 
reported that sanguinarine, in addition to be effective in displacing bound BH3 peptides, binds 
at the BH1 region of Bcl-XL, thus sanguinarine might antagonize other pro-survival 
mechanisms in addition to the one that involves BH3 region binding (Zhang et al., 2006). In 
this regard, a number of reports indicate that sanguinarine downregulates Bcl-2, thus altering 
the Bcl-2/Bax ratio in different tumor cells (Han et al., 2008; Kim et al., 2008; Lee et al., 
2012; Tsukamoto et al., 2011). Furthermore, recent evidence suggests that the anti-
proliferative activity of sanguinarine in malignant melanoma cells is independent of their p53 
status (Hammerova et al., 2011). 
Sanguinarine treatment has been reported to induce apoptosis in PC3 human prostatic 
adenocarcinoma cells through an early and severe glutathione (GSH)-depleting effect 
(Debiton et al., 2003). GSH is an endogenous antioxidant (Dodd et al., 2008) that acts as a 
redox buffer to preserve the reduced intracellular environment (Fraternale et al., 2006). Our 
present results show that sanguinarine induces a significant increase in oxidative stress in SK-
MEL-2 cells, and the thiol antioxidant NAC, which increases GSH level (Duyndam et al., 
2001; Menon et al., 2005), prevents an increase in ROS level, the release of mitochondrial 
apoptogenic proteins to the cytosol, as  well as cell death. In addition, we report here that 
GSH inhibits significantly the anti-melanoma activity of sanguinarine. Taken together, our 
data indicate that the oxidative stress triggered in melanoma cells by sanguinarine underlies 
the subsequent mitochondrial depolarization and release of mitochondrial apoptogenic 
proteins. 
By using sanguinarine self-fluorescence, nuclear accumulation of this alkaloid in 
mouse melanoma K1735-M2 cells has been observed (Serafim et al., 2008). Mitochondrial 
dysfunction was associated with nuclear DNA damage, and p53 was translocated to 
mitochondria upon sanguinarine treatment of mouse melanoma cells (Serafim et al., 2008). 
However, sanguinarine has also been reported to cause oxidative DNA damage and rapid 
apoptosis, that is not mediated by p53-dependent DNA damage signaling (Matkar et al., 
2008a; b). Here, we have found that human melanoma cells undergo a very rapid cell death 
response, which involves oxidative stress, following sanguinarine treatment. Thus, the 
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induction of a potent oxidative response seems to be critical for the anti-melanoma action of 
sanguinarine. 
The results reported here indicate that ROS generation, which in turn leads to 
mitochondrial dysfunction, is critical in sanguinarine-induced cell death in human melanoma 
cells. The rapid antitumor action of sanguinarine suggests that this drug could have a potential 
pharmaceutical application for the treatment of hyperproliferative skin disorders, including 
melanoma. 
 
5. Conclusions 
The data reported here show that sanguinarine induces a rapid caspase-dependent cell death in 
human melanoma cells, partially involving endoplasmic reticulum- and mitochondria-
mediated responses. This cell death is dependent on the generation of reactive oxygen species, 
and is not prevented by Bcl-XL overexpression. The fact that sanguinarine induces a very 
rapid cell death with apoptotic features in melanoma cells, together with the lack of inhibition 
by overexpressing Bcl-XL, highlight the potent anti-melanoma activity of this isoquinoline 
alkaloid and suggest its potential in the treatment of skin cancer. 
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FIGURE LEGENDS 
 
Fig. 1. Decrease of cell viability by sanguinarine in human melanoma cells. (A) SK-MEL-
2 cells were treated with 1, 2, 3, 4, 5 or 10 μM sanguinarine (Sang) for 2 and 24 h, and non-
viable cells were counted using the Trypan Blue Dye Exclusion assay. Untreated control cells 
(C) were run in parallel. Data shown are mean ± SD of three independent experiments. * p < 
0.05 vs. untreated control 2 h; # p < 0.05 vs. untreated control 24 h, one-way ANOVA test, 
Bonferroni post-test. (B) Different melanoma cell lines were treated with 3 μM sanguinarine 
(Sang) for 2 h, and non-viable cells were counted using the Trypan Blue Dye Exclusion assay. 
Untreated control cells (C) were run in parallel. Data shown are mean ± SD of three 
independent experiments. *
 
p < 0.05 vs. untreated control, Student’s t test. (C) Time-course of 
the decrease in cell viability induced by 3 μM sanguinarine in SK-MEL-2 cells. Data shown 
are mean ± SD of three independent experiments. *
 
p < 0.05 vs. untreated control, one-way 
ANOVA test, Bonferroni post-test. (D) Representative images of sanguinarine-treated SK-
MEL-2 cells for the indicated times. These images were extracted from time-lapse 
videomicroscopy recordings, in which untreated control SK-MEL-2 cells or SK-MEL-2 cells 
treated with 3 μM sanguinarine were recorded for 2 h. The images were captured by using 
differential interference contrast (DIC). Bar, 50 μm.  
 
Fig. 2. Caspase involvement in the cell-killing activity of sanguinarine on SK-MEL-2 
cells. (A) Cells untreated (C) or treated with 3 μM sanguinarine for the indicated times were 
analyzed by Western blot using specific antibodies. The migration positions of full-length 
PARP (116 kDa), and its cleavage product p85, as well as the cleavage products of several 
caspases are indicated. β-actin was used as a loading control in Western blot analyses. Blots 
are representative of two separate experiments performed. (B) SK-MEL-2 cells were 
preincubated with or without 50 μM of z-VAD-fmk for 1 h, and then incubated in the 
presence or absence of 3 μM sanguinarine (Sang) for 2 and 24 h. Then dead cells were 
counted using Trypan Blue Dye Exclusion method. Untreated control cells were run in 
parallel. Data shown are mean ± SD of three independent experiments. * p < 0.05 vs. 
untreated control 2 h; Φ p < 0.05 vs. Sang 2 h; # p < 0.05 vs. untreated control 24 h; θ p < 0.05 
vs. Sang 24 h, one-way ANOVA test, Bonferroni post-test. 
 
Fig. 3. Sanguinarine raises intracellular free calcium concentration in SK-MEL-2 cells. 
(A) Cells were incubated with 3 μM sanguinarine (Sang) for 2 h and then Fluo-4 AM (green 
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fluorescence) was used to visualize intracellular calcium. Hoechst 33342 stained nuclear 
DNA (blue fluorescence). Control image bar, 20 μm; sanguinarine image bar, 10 μm. (B) 
Cells were incubated with 3 μM sanguinarine (Sang) for 2 h, and then Fluo-4 AM (green 
fluorescence) was used to measure intracellular calcium by flow cytometry. Untreated control 
cells were run in parallel. Data shown are mean ± SD of five independent experiments. *
 
p < 
0.05 vs. untreated control, student’s t test. (C) SK-MEL-2 cells were untreated (C) or treated 
with 3 μM sanguinarine for the indicated times and analyzed by immunoblotting with anti-
BAP-31 antibody (SDS-15% polyacrylamide gels). The migration position of its cleavage 
product p20 is indicated. Immunoblotting for β-actin was used as an internal control for equal 
protein loading in each lane. Blots are representative of two independent experiments 
performed. (D) SK-MEL-2 cells were preincubated with or without 10 μM dantrolene for 1 h, 
and then incubated in the presence or absence of 3 μM sanguinarine (Sang) for 2 h and 24 h. 
Then dead cells were counted using Trypan Blue Dye Exclusion method. Untreated control 
cells were run in parallel. Data shown are mean ± SD of three independent experiments. * p < 
0.05 vs. untreated control 2 h; Φ p < 0.05 vs. Sang 2 h; # p < 0.05 vs. untreated control 24 h; θ 
p < 0.05 vs. Sang 24 h, one-way ANOVA test, Bonferroni post-test. 
 
Fig. 4. Sanguinarine induces mitochondrial dysfunction and ROS generation in SK-
MEL-2 cells. (A) Cells were incubated with 3 μM sanguinarine (Sang) for 2 h and then DHE 
was used to detect ROS production. Untreated control cells were run in parallel. Data shown 
are mean ± SD of four independent experiments. * p < 0.05 vs. untreated control, Student’s t 
test. (B) Cells were incubated in the absence (Control) and in the presence of 3 μM 
sanguinarine (Sang), and then DHE (red fluorescence) was used to visualize oxygen radicals 
by confocal microscopy. DHE is oxidized into fluorescent ethidium by the superoxide ion. 
Hoechst 33342 stained nuclear DNA (blue fluorescence). Bar, 25μm. (C) SK-MEL-2 cells 
were treated with 1, 2, 3, 4, 5 or 10 μM sanguinarine (Sang) for 2 and 24 h, and then 
DiOC6(3) (green fluorescence) was used to measure the percentage of cells with high and low 
mitochondrial membrane potential (ΔΨm) by flow cytometry. Untreated control cells were run 
in parallel. Data shown are mean ± SD of three independent experiments. * p < 0.05 vs. 
untreated control 2 h; # p < 0.05 vs. untreated control 24 h, one-way ANOVA test, Bonferroni 
post-test. (D) Cells were incubated without or with 3 μM of sanguinarine for 2 h and then 
TMRM (red fluorescence) was used to measure mitochondrial membrane potential (ΔΨm) by 
flow cytometry. Untreated control cells were run in parallel. Data shown are mean ± SD of 
four independent experiments. *
 
p < 0.05 vs. untreated control, Student’s t test. (E) SK-MEL-
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2 cells treated with 3 μM sanguinarine for the indicated times, and cytosolic proteins were 
analyzed by immunoblotting with anti-cytochrome c (Cyt c) and Smac/DIABLO antibodies. 
β-actin serves as an internal control for equal protein loading in each lane. Data shown are 
representative of two experiments performed. 
 
Fig. 5. Bcl-XL overexpression does not prevent sanguinarine-induced decrease in cell 
viablity, ROS generation and release of mitochondrial apoptogenic proteins in SK-
MEL-2 cells. (A) Neo and Bcl-XL transfected cells were untreated (C) or treated with 3 µM 
sanguinarine (Sang) for 2 h and assayed for cell viability by the Trypan Blue Dye Exclusion 
assay. Data shown are mean ± SD of five independent experiments. * p < 0.05 vs. untreated 
control Neo; # p < 0.05 vs. untreated control Bcl-XL, one-way ANOVA test, Bonferroni post-
test. Inset, Bcl-XL protein expression in SK-MEL-2-Neo and SK-MEL-2-Bcl-XL cells was 
analyzed by SDS-PAGE of 40 µg cell extract protein and immunoblotting. β-actin was used 
as a control for protein loading. (B) Neo and Bcl-XL transfected cells were untreated (C) or 
treated with 3 µM sanguinarine (Sang) for 2 h and assayed for PARP cleavage. The migration 
positions of full-length PARP (116 kDa) and its cleavage product p85 are indicated. 
Immunoblotting for β-actin was used as an internal control for equal protein loading in each 
lane. Blots are representative of two separated experiments. (C) Bcl-XL overexpression did 
not prevent sanguinarine-induced ROS production. SK-MEL-2 cells (Neo) and Bcl-XL-
transfected SK-MEL-2 cells (Bcl-XL) were treated with 3 µM sanguinarine (Sang) for 2 h, and 
then analyzed for ROS generation (using DHE). Untreated control cells (control) were run in 
parallel. Data shown are mean ± SD of four independent experiments. * p < 0.05 vs. untreated 
control Neo; # p < 0.05 vs. untreated control Bcl-XL; + p < 0.05 vs. Sang Neo, one-way 
ANOVA test, Bonferroni post-test. (D) Bcl-XL overexpression did not prevent sanguinarine-
induced release of apoptogenic proteins from mitochondria. Neo and Bcl-XL transfected cells 
were untreated (C) or treated with 3 µM sanguinarine (Sang) for 2 h and cytosolic fractions 
were analyzed by immunoblotting with anti-cytochrome c (Cyt c) and Smac/DIABLO 
antibodies. β-actin serves as an internal control for equal protein loading in each lane. Data 
shown are representative of two separated experiments. 
Fig. 6. Involvement of ROS generation in the antitumor action of sanguinarine in SK-
MEL-2 cells. (A) SK-MEL-2 cells were preincubated without or with 10 mM NAC for 30 
min, and then incubated in the presence or absence of 3 µM sanguinarine (Sang) for 1 h, and 
dead cells were determined using Trypan Blue. Untreated control cells (C) were run in 
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parallel. Data shown are mean ± SD of three independent experiments. * p < 0.05 vs. untreated 
control; # p < 0.05 vs. Sang, one-way ANOVA test, Bonferroni post-test.  (B) SK-MEL-2 cells 
were preincubated with or without 10 mM NAC for 30 min, and then incubated in the 
presence or absence of 3 µM sanguinarine (Sang) for 2 h and analyzed by immunoblotting 
with anti-PARP antibody (SDS-8% polyacrylamide gels). The migration positions of full-
length PARP (116 kDa) and its cleavage product p85 are indicated. Immunoblotting for β-
actin was used as an internal control for equal protein loading in each lane. Blots are 
representative of two experiments performed. (C) Cells were preincubated with or without 10 
mM NAC for 30 min, and then incubated in the presence or absence of 3 µM sanguinarine 
(Sang) for 2 h. Then ROS production was measured by flow cytometry. Data shown are mean 
± SD of four independent experiments. * p < 0.05 vs. untreated control; # p < 0.05 vs. Sang, 
one-way ANOVA test, Bonferroni post-test. (D) Cells were preincubated with or without 10 
mM NAC for 30 min, and then incubated in the presence or absence of 3 µM sanguinarine 
(Sang) for 2 h. Cytosolic proteins were analyzed by immunoblotting anti-cytochrome c (Cyt 
c) and Smac/DIABLO antibodies. β-actin serves as an internal control for equal protein 
loading in each lane. Untreated control cells (C) were run in parallel in A-D. Data shown are 
representative of two experiments performed. 
Fig. 7. Glutathione preincubation inhibits the sanguinarine-induced decrease in cell 
viability of SK-MEL-2 melanoma cells. SK-MEL-2 cells were preincubated with or without 
10 mM GSH for 1 h, and then incubated in the presence or absence of 3 μM sanguinarine 
(Sang) for 2 and 24 h. Then non-viable cells were counted using Trypan Blue Dye Exclusion 
method. Untreated control cells were run in parallel. Data shown are mean ± SD of three 
independent experiments. * p < 0.05 vs. untreated control 2 h; Φ p < 0.05 vs. Sang 2 h; # p < 
0.05 vs. untreated control 24 h; θ p < 0.05 vs. Sang 24 h, one-way ANOVA test, Bonferroni 
post-test. 
 
SUPPLEMENTARY MATERIAL (VIDEOS) 
Supplementary Video 1. Time-lapse videomicroscopy of untreated control SK-MEL-2 cells, 
grown in complete RPMI-1640 culture medium supplemented with 15% heat-inactivated 
FBS. Recording time: 3 h. Magnification: 20x. 
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Supplementary Video 2. Time-lapse videomicroscopy of the effect of sanguinarine on SK-
MEL-2 cells. Film recording started immediately after addition of 3 µM sanguinarine on SK-
MEL-2 cells grown in complete RPMI-1640 culture medium supplemented with 15% heat-
inactivated FBS. Recording time: 3 h. Magnification: 20x. 
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